Rodney F Minchin

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Pharmacological reviews

ACS pharmacology & translational science

Molecular pharmaceutics

Drug metabolism and disposition: the biological fate of chemicals

University of Queensland

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Queensland Oct 01 2003

Australia

Chair of molecular pharmacology :: School of biomedical sciences

Publications

Chandra Choudhury, Melinder K Gill, Courtney E McAleese, Neville J Butcher, Shyuan T Ngo, Frederik J Steyn, Rodney F Minchin
The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction. Pharmacological reviews 76 (2) (2024)
Chandra Choudhury, James E Egleton, Neville J Butcher, Angela J Russell, Rodney F Minchin
Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration. ACS pharmacology & translational science 7 (8) (2024)
Chandra Choudhury, Melinder K Gill, Courtney E McAleese, Neville J Butcher, Shyuan T Ngo, Frederik J Steyn, Rodney F Minchin
The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction. Pharmacological reviews 76 (2) (2024)
Chandra Choudhury, James E Egleton, Neville J Butcher, Angela J Russell, Rodney F Minchin
Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration. ACS pharmacology & translational science 7 (8) (2024)
Christopher N Subasic, Neville J Butcher, Fiona Simpson, Rodney F Minchin, Lisa M Kaminskas
Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats. Molecular pharmaceutics (2023)
Christopher N Subasic, Neville J Butcher, Rodney F Minchin, Lisa M Kaminskas
Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats. Molecular pharmaceutics (2023)
Chandra Choudhury, Courtney E McAleese, Neville J Butcher, Rodney F Minchin
Contrasting Effects of Temperature on Human Arylamine N -Acetyltransferase and Acetyl Coenzyme A Hydrolase Activities. Biochemistry (2023)
Courtney E McAleese, Neville J Butcher, Rodney F Minchin
Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis. Breast cancer research and treatment 195 (3) (2022)
Pengcheng Li, Neville J Butcher, Rodney F Minchin
Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV. Cell adhesion & migration 14 (1) (2021)
Colton D Payne, Bastian Franke, Mark F Fisher, Fatemeh Hajiaghaalipour, Courtney E McAleese, Angela Song, Carl Eliasson, Jingjing Zhang, Achala S Jayasena, Grishma Vadlamani, Richard J Clark, Rodney F Minchin, Joshua S Mylne, K Johan Rosengren
A chameleonic macrocyclic peptide with drug delivery applications. Chemical science 12 (19) (2021)
Misgana Idris, Neville J Butcher, Rodney F Minchin
The MBNL/CELF Splicing Factors Regulate Cytosolic Sulfotransferase 4A1 Protein Expression during Cell Differentiation. Drug metabolism and disposition: the biological fate of chemicals 47 (3) (2019)
LiLi Wang, Rodney F Minchin, Neville J Butcher
Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability. PloS one 13 (3) (2018)
Rodney F Minchin, Neville J Butcher
Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance. BMC genomics 19 (1) (2018)

Rodney F Minchin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rodney F Minchin